Citation Impact
Citing Papers
Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
2012
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
2009
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
2011
A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors
2004
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2012
Inhibition of Macrophage Migration Inhibitory Factor or Its Receptor (CD74) Attenuates Growth and Invasion of DU-145 Prostate Cancer Cells
2006
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
2009
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
2009
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer
2013
Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells
2010
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
2019
Hepatocellular carcinoma
2018 Standout
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years
2003
The nuclear protein HMGB1, a new kind of chemokine?
2003
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Significance of circulating endothelial progenitor cells in hepatocellular carcinoma†
2006
Macrophage Migration Inhibitory Factor Promotes Intestinal Tumorigenesis
2005
Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients
2009
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
2012
The biology and function of fibroblasts in cancer
2016 Standout
Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
2009
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
2007 Standout
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Hepatocellular carcinoma
2021 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Scleroderma
2009 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
2004
Cellular processing of platinum anticancer drugs
2005 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Cytokine patterns in patients with cancer: a systematic review
2013 Standout
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
2014
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1
2006
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Neutrophils, from Marrow to Microbes
2010 Standout
Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner
2008 StandoutNobel
Microenvironmental regulation of metastasis
2008 Standout
Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?
2016
Macrophage Migration Inhibitory Factor: A Probable Link between Inflammation and Cancer
2007
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Hepatocellular Carcinoma
2011 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Hepatocellular carcinoma
2022 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Stimulation of Vascular Smooth Muscle Cell Migration by Macrophage Migration Inhibitory Factor
2005
The role of EGF ‐EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
2013
Hepatocellular Carcinoma
2019 Standout
The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer
2005
Distinct Role of Macrophages in Different Tumor Microenvironments
2006 Standout
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
2017
Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis
2004
Chemokines
2004
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Macrophage Migration Inhibitory Factor Increases Leukocyte–Endothelial Interactions in Human Endothelial Cells via Promotion of Expression of Adhesion Molecules
2010
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis
2012
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
2007
Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
2013
Works of Wun‐Ching Yu being referenced
Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma
2001
Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma
2003
Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
2003
Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study
2002
Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
2003
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy
1997
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy
1997